Financial Results Summary Three Months Ended December 31, 2012For the three months ended December 31, 2012, Mylan reported total revenues of $1.72 billion compared to $1.53 billion in the comparable prior year period, an increase of $191.7 million or 12.5%. The effect of foreign currency translation had an unfavorable impact of approximately 2% on total revenues primarily reflecting a stronger U.S. Dollar in comparison to the currencies of the other major markets in which Mylan operates. Translating total revenues for the current quarter at prior year comparative period exchange rates would have resulted in year-over-year growth of approximately $216 million, or 14%.
A tabular summary of Mylan's revenues for the three months and years ended December 31, 2012 and 2011 is included at the end of this release. Also included at the end of this release are the reconciliations of adjusted financial results to the most closely applicable GAAP financial result.
Third party net revenues from Mylan's Generics segment, which are derived from sales in North America, Europe, the Middle East and Africa (collectively, EMEA) and Australia, India, Japan and New Zealand (collectively, Asia Pacific) were $1.56 billion in the quarter ended December 31, 2012, compared to $1.42 billion in the comparable prior year period, representing an increase of $141.7 million, or 10.0%, or an increase of approximately 12% when excluding the unfavorable effect of foreign currency translation.
Third party net revenues from North America were $810.9 million for the current quarter, compared to $737.1 million for the comparable prior year period, representing an increase of $73.9 million, or 10.0%. The increase in third party net revenues was principally due to sales of new products launched during 2012, which totaled approximate
|SOURCE Mylan Inc.|
Copyright©2012 PR Newswire.
All rights reserved